Health News Roundup: Fresenius to assess whether state aid impacts bonus, dividend payouts; Cigna Group announces settlement with US on claims it overcharged Medicare Advantage program and more

Following is a summary of current health news briefs. Fresenius to assess whether state aid impacts bonus, dividend payouts German healthcare group Fresenius said it was examining whether the state aid it received to help offset high energy costs at its hospitals business would bar it from making management bonus and dividend payments.

Following is a summary of current health news briefs.

Fresenius to assess whether state aid impacts bonus, dividend payouts

German healthcare group Fresenius said it was examining whether the state aid it received to help offset high energy costs at its hospitals business would bar it from making management bonus and dividend payments. "Fresenius is examining the pertinent rules and the legal repercussions very carefully at the moment," a company spokesperson said in a statement, adding it would discuss the matter with a new German regulatory body.

Cigna Group announces settlement with US on claims it overcharged Medicare Advantage program

Health insurer Cigna Group says it has reached a settlement with the United States over claims it overcharged the government's Medicare Advantage program by making it appear patients were more ill than they actually were. The settlement, reached on Friday, includes a payment of about $172 million by Cigna. Cigna said it also will enter into a corporate integrity agreement with the U.S. Office of Inspector General.

Drugmaker Viatris to divest some of its businesses

Drugmaker Viatris said on Sunday that it has entered into agreements to divest its businesses, including the Women's Healthcare business and its Active Pharmaceutical Ingredients (API) business. It also received an offer for the divestiture of its Over-the-Counter (OTC) business. Viatris will divest its API business in India to an Indian pharmaceutical company, Iquest Enterprises, the company said. The transaction includes three manufacturing sites and an R&D lab.